3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Hepatocellular
38
Neoplasm Metastasis
14
Liver Neoplasms
11
Colorectal Neoplasms
11
Cholangiocarcinoma
9
Pancreatic Neoplasms
8
Lung Neoplasms
8
Colonic Neoplasms
7
Breast Neoplasms
7
Thyroid Nodule
6
Recurrence
6
Carcinoma, Renal Cell
6
Carcinoma, Non-Small-Cell Lung
6
Thyroid Neoplasms
5
Rectal Neoplasms
4
Neoplasms
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Pain
3
Kidney Neoplasms
3
Barrett Esophagus
3
Agnosia
3
Thyroid Diseases
2
Thyroid Cancer, Papillary
2
Leiomyoma
2
Hyperaldosteronism
2
Gallbladder Neoplasms
2
Cancer Pain
2
Bile Duct Neoplasms
2
Adrenocortical Adenoma
2
Interventions
Tamoxifen
3
pyrotinib
2
abemaciclib
2
Metformin
2
Letrozole
2
Exercise
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
palbociclib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tumor Burden
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Sodium Chloride
1
Self-Help Groups
1
Saline Solution
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Breast Cancer Female
×
Radiofrequency Ablation
×
Clear all
NCT04389216
2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA
Completed
30 enrolled